In vivo administration of recombinant growth hormone or gamma interferon activates macrophages: Enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates

Infection and Immunity

Volumn 60, Issue 6, 1992, Pages 2514-2521

  Edwards III, C K ^a   Ghiasuddin, S M ^a   Yunger, L M ^a   Lorence, R M ^a   Arkins, S ^a   Dantzer, R ^a   Kelley, K W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; PROLACTIN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT GROWTH HORMONE; SUPEROXIDE; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; HYPOPHYSIS; INFECTION RESISTANCE; MACROPHAGE ACTIVATION; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; SALMONELLA TYPHIMURIUM; SALMONELLOSIS;

ANIMAL; FEMALE; GROWTH HORMONE; HYDROGEN PEROXIDE; HYPOPHYSECTOMY; IMMUNITY, NATURAL; INTERFERON-GAMMA, RECOMBINANT; MACROPHAGE ACTIVATION; PHAGOCYTOSIS; RATS; RATS, INBRED STRAINS; RECOMBINANT PROTEINS; SALMONELLA INFECTIONS; SUPEROXIDES; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026755654     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)